trending Market Intelligence /marketintelligence/en/news-insights/trending/xsDXj8XSvQuWbk_tsLvaGw2 content esgSubNav
In This List

Agios board member to resign

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Agios board member to resign

Lewis Cantley will resign as a director of Agios Pharmaceuticals Inc., effective Dec. 31.

Cantley is resigning due to other commitments and not because of any disagreement with the company on any matter relating to its operations, policies or practices.

Cantley will continue to serve on the company's scientific advisory board.